Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Aerovate Therapeutics Q3 EPS $(0.26)

Aerovate Therapeutics (NASDAQ:AVTE) reported quarterly losses of $(0.26) per share.

byBenzinga Newsdesk

November 15, 2021

1 minute read

Aerovate Therapeutics (NASDAQ:AVTE) reported quarterly losses of $(0.26) per share.

News

The Information Reports Google Cloud’s Top U.S. Sales Execs Depart in Shakeup as Profits Remain Elusive

By Charles Gross

Today, 4:12 AM

https://www.theinformation.com/articles/google-clouds-top-u-s-sales-execs-depart-in-shakeup-as-profits-remain-elusive

GOOG

News

CarLotz Reports Opening Of 3 New Hubs In The US: Bakersfield, California, Clearwater, Florida, Highland Park, Illinois

By Benzinga Newsdesk

Today, 4:12 AM

CarLotz (NASDAQ:LOTZ), the nation’s largest consignment-to-retail used vehicle marketplace, announced today it has opened three new hubs across the country. The hubs, located in Bakersfield, CA, Clearwater,

LOTZ

News

Facebook Documents Show Company Inadequately Stops Human Traffickers, Drug Cartels From Posting

By Benzinga Newsdesk

Today, 4:12 AM

-Dow Jones

Legal
News

Biodesix European Patent Office Specification For Co.’s ‘BLOOD SAMPLE SEPARATION DEVICES AND METHODS’

By Benzinga Newsdesk

Today, 4:12 AM

https://data.epo.org/publication-server/pdf-document?pn=3705042&ki=B1&cc=EP

BDSX

Aerovate Therapeutics Q3 EPS $(0.26)

Related Posts

The Information Reports Google Cloud’s Top U.S. Sales Execs Depart in Shakeup as Profits Remain Elusive

CarLotz Reports Opening Of 3 New Hubs In The US: Bakersfield, California, Clearwater, Florida, Highland Park, Illinois

Facebook Documents Show Company Inadequately Stops Human Traffickers, Drug Cartels From Posting

Biodesix European Patent Office Specification For Co.’s ‘BLOOD SAMPLE SEPARATION DEVICES AND METHODS’